Targeted next-generation sequencing in children with intellectual disabilities, autism spectrum disorders and multiple congenital abnormalities
Ontology highlight
ABSTRACT: We performed a targeted NGS using the commercial gene panel design ClearSeq Inherited Disease (Agilent Technologies) to identify the pathogenic sequence variants in children with ID/DD, ASD and MCA and their unaffected parents
INSTRUMENT(S): NextSeq 500
ORGANISM(S): Homo sapiens
SUBMITTER: Marketa Wayhelova
PROVIDER: E-MTAB-8041 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA